Potential Cure for Sickle Cell Clears Hurdle for Approval
(MedPage Today) -- An FDA advisory committee meeting on Tuesday did nothing to dispel expectations that the investigational agent exagamglogene autotemcel (exa-cel) will become the first approved gene therapy for sickle cell disease (SCD).
Members...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Gene Therapy | Genetics | International Medicine & Public Health | Sickle Cell Anemia